BTK and arthritic joint disease: And this phenotype was also observed in BTK inhibitor PCI-32765 and canonical anti-inflammatory drug MTX treated groups (Fig. 3g) All the above results indicated that CHMFL-BTK-11 overall exhibited good anti-inflammatory efficacy in the rodent adjuvant-induced arthritis model.